Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | IDO1 | P14902 | 5/20 | 0.55 |
| ▸ | PANK3 | Q9H999 | 2/20 | 0.54 |
| ▸ | TDO2 | P48775 | 3/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12048865 | 0.87 | PDGFRB (0.52) | ALDH1A1LMNAMAPTMAPK1IDO1 | |
| SCHEMBL12048875 | 0.84 | MAPT (0.61) | ALDH1A1LMNAMAPTMAPK1IDO1 | |
| SCHEMBL21137993 | 0.78 | IDO1 (0.81) | IDO1TDO2CYP2C8CYP2C9 | |
| SCHEMBL21138051 | 0.78 | KDM4E (0.55) | ALDH1A1MAPTIDO1TDO2NPC1 | |
| SCHEMBL4964417 | 0.76 | IDO1 (0.47) | ALDH1A1MAPTIDO1TDO2FAAH | |
| SCHEMBL21061072 | 0.75 | IDO1 (0.50) | ALDH1A1MAPTIDO1TDO2NPC1 | |
| SCHEMBL21289330 | 0.75 | IDO1 (0.82) | IDO1TDO2CYP2C8CYP2C9 | |
| SCHEMBL15152945 | 0.74 | MAPK7 (0.42) | ALDH1A1MAPTIDO1TDO2CYP2C8 | |
| SCHEMBL903158 | 0.74 | MAPK7 (0.42) | ALDH1A1MAPTIDO1TDO2CYP2C8 | |
| SCHEMBL18806739 | 0.73 | IDO1 (0.76) | IDO1TDO2CYP2C8CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8071768-B2 | Alkylquinoline and alkylquinazoline kinase modulators | JANSSEN PHARMACEUTICA, N.V. (BE) | 2011-12-06 | — | — | US | disclosed |
| US-8071768-B2 | Alkylquinoline and alkylquinazoline kinase modulators | JANSSEN PHARMACEUTICA, N.V. (BE) | 2011-12-06 | — | — | US | disclosed |
| US-20070004660-A1 | Synergistic Modulation of Flt3 Kinase Using Alkylquinolines and Alkylquinazolines | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004660-A1 | Synergistic Modulation of Flt3 Kinase Using Alkylquinolines and Alkylquinazolines | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004660-A1 | Synergistic Modulation of Flt3 Kinase Using Alkylquinolines and Alkylquinazolines | FLT3, MCL1, CDC42BPG | ALDH1A1 2810/4885LMNA 1575/4885MAPT 4814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.